Highlights Cue Health Inc.

Equities

HLTHQ

US2297901009

Market Closed - OTC Markets Other stock markets 01:29:59 29/06/2024 am IST			5-day change	1st Jan Change
0.0055 ^USD	-17.91%		-29.49%	-96.62%

20/06	Motion for Asset Sale Filed by Cue Health Inc.	CI
10/06	Cue Health Inc.(OTCPK:HLTH.Q) dropped from S&P TMI Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cue Health Says It Is Evaluating FDA Warning Letter Over COVID-19 Test	14/05	MT
Cue Health Inc. Receives Response Letter from the U.S. Food and Drug Administration Regarding Its De Novo Request	09/04	CI
North American Morning Briefing : Inflation -2-	15/03	DJ
Earnings Flash (HLTH) CUE HEALTH Posts Q4 Revenue $18.8M, vs. Street Est of $17.7M	14/03	MT
Cue Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/03	CI
Cue Health Inc. Provides Revenue Guidance for the First Quarter of 2024	14/03	CI
Cue Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Earnings Flash (HLTH) CUE HEALTH Reports Q3 Revenue $17.5M, vs. Street Est of $11.2M	09/11	MT
Cue Health Inc. Provides Revenue Guidance for the Fourth Quarter of 2023	09/11	CI
Cue Health Inc. Declares Dividend Distribution	22/23/22	CI
Cue Health Shareholder Tarsadia Seeks Strategic Review, Shareholder Representation on Board	01/23/01	MT
Investor Tarsadia urges Cue Health to review options, add new director	01/23/01	RE
Cue Health Shareholder Tarsadia Seeks Strategic Review, Shareholder Representation on Board	31/23/31	MT
Investor Tarsadia urges Cue Health to review options, add new director	31/23/31	RE
Earnings Flash (HLTH) CUE HEALTH Posts Q2 Revenue $9.9M, vs. Street Est of $8.9M	10/23/10	MT
Cue Health Inc. Provides Revenue Guidance for Third Quarter of 2023	10/23/10	CI
Cue Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
Cue Health Gets $28 Million Federal Contract	04/23/04	MT
Cue Health Inc. Announces Award of New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use	04/23/04	CI
Cue Health's COVID-19 Molecular Test Gets US FDA's Marketing Authorization	07/23/07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cue Health Inc.

Equities

HLTHQ

US2297901009

Highlights

Filters